The 65h JSAP Spring Meeting, 2018

Presentation information

Oral presentation

8 Plasma Electronics » 8.4 Plasma life sciences

[19p-C201-1~19] 8.4 Plasma life sciences

Mon. Mar 19, 2018 1:45 PM - 7:00 PM C201 (52-201)

Satoshi Uchida(Tokyo Metropolitan Univ.), Masafumi Ito(Meijo Univ.), Tsunehiro Maehara(Ehime Univ.)

2:15 PM - 2:30 PM

[19p-C201-3] Elucidation of the antitumor effect of Plasma-Activated Lactec

〇(M1)Yugo Hosoi1, Kenji Ishikawa1, Hiroshi Hashizume2, Hiromasa Tanaka2, Fumitaka Kikkawa3, Masaaki Mizuno3, Masaru Hori2 (1.Nagoya Univ. Eng., 2.Nagoya Univ. Inst. Innovation for Future Society, 3.Nagoya Univ. Med.)

Keywords:Plasma Medicine, Plasma-Activated Medium, Plasma-Activated Lactec

We have reported the selective killing of cancer cells incubated in plasma-activated lactate in Ringer's solution (Lactec), so called as PAL. We focused on PAL's antitumor agents other than RONS. As a result, the PAL may induce the apoptotic death by unresolved antitumor agent other than RONS. It was suggested that plasma-activated lactate had antitumor effects.